Back to search

Dysplasia Diagnostics Limited

14361617

active
Private Limited Company
Companies House
Health Score
70 / 100

Some Concerns

30/30
Filing
0/30
Financial
40/40
Risk
  • Negative net worth (-10)
  • Loss before tax (-10)
  • Current liabilities exceed current assets (-10)
  • Going concern doubt noted in accounts (-10)

Details

85 GREAT PORTLAND STREET, LONDON, W1W 7LT
Incorporated 16/09/2022

Compliance

Accounts

Up to date

Confirmation statement

Up to date

Industry

72110
Research and experimental development on biotechnology
72190
Other research and experimental development on natural sciences and engineering

Officers

Mrs Denise Williams

director · Since 16/09/2022

MANAGING DIRECTOR

BRITISH · UNITED KINGDOM · Age 43

Also on 1 other board

Dr Osagie Izuogu

director · Since 31/07/2023

DIRECTOR

BRITISH · ENGLAND · Age 45

Persons with Significant Control

Osagie Izuogu

50–75% shares
50–75% votes
Appoint directors

Nigerian · United Kingdom · Age 45

85, Great Portland Street, London, W1W 7LT

Notified 16/09/2022

CompanyRankvs 2552+ SIC 72110 peers
27

Financial strength10th percentile among SIC peers · 3/25
Employees85th percentile among SIC peers · 13/15
LiquidityCurrent ratio 0.05× · 2/20
Longevity4 years trading (max 15) · 4/15
Filing complianceAll filings up to date · 15/15
Going concern doubt -10
Show leaderboard
1Werfen Limited
90
2Biopharma Process Systems Limited
90
3Theradex (Europe) Limited
90
4Spicer Consulting Limited
90
5Exmoor Pharma Concepts Limited
90
6Ubc Late Stage (Uk) Limited
90
7Wuxi Apptec Uk Ltd
90
8Bio - Diagnostics Limited
89
9Biointeractions Limited
89
10Ams Advanced Medical Services Limited
89
2552Dysplasia Diagnostics Limited
36
How is this score calculated?
Financial strength3/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees13/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity2/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity4/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Risk deductions

Going concern doubt: -10 pts

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Going Concern Doubt

book value At 30 September 2025 210 At 30 September 2024 340 Page 11 DYSPLASIA DIAGNOSTICS LIMITED Notes to the Financial Statements for the Period Ended 30 September 2025 5. Financial Commitments Going concern The company incurred net liabilities of £70,737 as at 30 September 2025. Nevertheless, the directors have assessed the company's ability to continue as a going concern for a period of at

Key FinancialsYear ending 30/09/2025

Net Worth

-£71k

Balance sheet strength

Cash

£2k

Cash in the bank

Profit Before Tax

-£34k

Bottom line earnings

Net Current Assets

-£71k

Working capital

Current Assets

£4k

Current Liabilities

£75k

Fixed Assets

£210

Debtors

£2k

Gross Profit

-£34k

Operating Profit

-£34k

Profit After Tax

-£34k

5avg. employees+2

Balance Sheet

Assets less current liabilities-£71k
Signed by 1.10.24Prepared with Company Accounts and Tax Online

EstimatesDerived

YearCurrent RatioImplied Profit
20250.05-£34k
20240.02-£10k
20230.20—

Derived from filed accounts. Not audited figures.